Recommendations for treatment algorithm of HFrEF

10' education - Apr. 26, 2021 - Andrew Coats, MD - University of Warwick, Coventry, UK & Monash University, Melbourne, Australia

Video navigation menu

Benefits of combinations of recommended therapies in HFrEF 02:27
The majority of patients with HF are not on target dose 04:54
Limitations of the current guideline 07:04
Recommendations for the treatment of HFrEF 09:54

Educational information

This presentation was broadcasted at the e-SPACE CRM conference, a global web-conference on the cardio-renal-metabolic syndrome, that was held January 22-24, 2021.

Faculty

Andrew Coats, MD is Academic Vice-President at University of Warwick, Coventry, UK and Monash University, Melbourne, Australia. He is also president of the Heart Failure Association of the ESC.

Disclosures

This recording was independently developed under auspices of PACE-cme. The views expressed in this recording are those of the individual presenter and do not necessarily reflect the views of PACE-cme.

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.